World's Best Scientists 2026 revealed!
Wolfgang Koenig

Wolfgang Koenig

Award Badge
Medicine
Germany
2026

D-Index & Metrics

Medicine

D-Index
159
Citations
140471
World Ranking
799
National Ranking
35

Research.com Recognitions

  • 2026 - Research.com Medicine in Germany Leader Award
  • 2023 - Research.com Medicine in Germany Leader Award

Overview

Wolfgang Koenig is affiliated with the University of Ulm in Germany and has contributed extensively to the field of medicine, with a focus on cardiology and cardiovascular medicine. The scope of their research spans various subfields, including surgery, molecular biology, endocrinology, diabetes and metabolism, and immunology.

The scientist's work concentrates primarily on topics related to cardiovascular health and metabolic diseases. Main topics include lipoproteins and cardiovascular health, adipokines, inflammation, and metabolic diseases, diabetes and cardiovascular risks associated with lipoproteins, health systems and economic evaluations, atherosclerosis and cardiovascular diseases, cardiac imaging and diagnostics, and acute myocardial infarction research.

Wolfgang Koenig has published in several major scientific journals, commonly appearing in these venues:

  • European Heart Journal
  • Journal of the American College of Cardiology
  • Atherosclerosis
  • European Journal of Preventive Cardiology
  • Circulation

Selected recent papers include:

  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice, 2021, European Heart Journal
  • Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol, 2020, New England Journal of Medicine
  • Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk, 2020, JAMA
  • Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia, 2020, New England Journal of Medicine
  • Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality, 2023, New England Journal of Medicine

Frequent collaborators of Wolfgang Koenig include Annette Peters, Barbara Thorand, Kausik K. Ray, Frederick J. Raal, and Ulf Landmesser. These coauthors have appeared alongside them in numerous research papers, reflecting collaboration within cardiovascular and metabolic disease research communities.

Best Publications

  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

    Paul M Ridker;Brendan M. Everett;Tom Thuren;Jean G. MacFadyen

  • Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

    Paul M. Ridker;Eleanor Danielson;Francisco A. H. Fonseca;Jacques Genest

  • Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

    Kunihiro Matsushita;Marije van der Velde;Brad C. Astor;Mark Woodward

  • From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

    Morteza Naghavi;Peter Libby;Erling Falk;S. Ward Casscells;S. Ward Casscells

  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    Frank L J Visseren;François Mach;Yvo M Smulders;David Carballo

  • Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy

    Christian Templin;Jelena R. Ghadri;Johanna Diekmann;L. Christian Napp

  • Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

    Jean-Claude Tardif;Simon Kouz;David D. Waters;Olivier F. Bertrand

  • Large-scale association analysis identifies new risk loci for coronary artery disease

    Panos Deloukas;Stavroula Kanoni;Christina Willenborg;Martin Farrall

  • Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

    J Danesh;S Lewington;S G Thompson;Lowe Gdo.

  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

    Paul M Ridker;Jean G MacFadyen;Tom Thuren;Brendan M Everett

  • Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators

    Bart Staels;Wolfgang Koenig;Aïda Habib;Régine Merval

  • Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.

    Paul M Ridker;Eleanor Danielson;Francisco Ah Fonseca;Jacques Genest

  • C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction

    Stephen Kaptoge;Emanuele Di Angelantonio;Lisa Pennells;Angela M. Wood

  • Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial

    Stephen J. Nicholls;Stephen J. Nicholls;Rishi Puri;Todd Anderson;Christie M. Ballantyne

  • Two Phase 3 Trials of Inclisiran in Patients With Elevated LDL Cholesterol

    Kausik K. Ray;R. Scott Wright;David Kallend;Wolfgang Koenig;Wolfgang Koenig

  • How to use high-sensitivity cardiac troponins in acute cardiac care

    Kristian Thygesen;Johannes Mair;Evangelos Giannitsis;Christian Mueller

  • Association between C-reactive protein and features of the metabolic syndrome: a population-based study.

    Margit Fröhlich;Armin Imhof;Gabriele Berg;Winston L. Hutchinson

  • New loci associated with kidney function and chronic kidney disease

    Anna Köttgen;Anna Köttgen;Cristian Pattaro;Carsten A. Böger;Christian Fuchsberger

  • A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism

    Robert J. Glynn;Eleanor Danielson;Francisco A.H. Fonseca;Jacques Genest

  • Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

    Paul M Ridker;Jean G MacFadyen;Brendan M Everett;Peter Libby

Frequent Co-Authors

Annette Peters
Annette Peters Ludwig-Maximilians-Universität München
Barbara Thorand
Barbara Thorand Helmholtz Zentrum München
Christa Meisinger
Christa Meisinger University of Augsburg
Dietrich Rothenbacher
Dietrich Rothenbacher University of Ulm
Christian Herder
Christian Herder Heinrich Heine University Düsseldorf
Hermann Brenner
Hermann Brenner German Cancer Research Center
Paul M. Ridker
Paul M. Ridker Brigham and Women's Hospital
Thomas Illig
Thomas Illig Hannover Medical School
Wolfgang Rathmann
Wolfgang Rathmann Heinrich Heine University Düsseldorf
Winfried März
Winfried März Medical University of Graz

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering alternative routes in healthcare beyond traditional medical school, a variety of online options now make it easier to start or advance your career. Many students explore accelerated nursing pathways, such as online direct entry msn programs for non-nursing majors. These programs are ideal for individuals with a bachelor’s degree in another field who wish to quickly pivot into advanced nursing roles.

For those just starting out or without a prior nursing degree, online adn programs for non nurses provide a flexible entry point, leading to licensure and employment opportunities as a registered nurse.

Not all healthcare roles require clinical work. Administrative fields like medical billing and coding are in high demand, and you can find medical coding and billing classes online with financial aid to help you break into this essential area.

For licensed practical nurses (LPNs) wanting to become registered nurses (RNs) without extensive standardized test requirements, some schools now offer lpn to rn programs without teas test, removing a significant barrier to career progression.

Best Scientists Citing Wolfgang Koenig

Trending Scientists

Recently Published Articles